Michael A. Egan

Corporate Officer/Principal at Profectus BioSciences, Inc.

Consumer Services

Health Technology

Commercial Services

Profile

Michael A.
Egan is currently the Immunology Director at Profectus BioSciences, Inc. He previously worked as a Principal Research Scientist at Wyeth Research.
Egan received his undergraduate degree from Northern Arizona University and his doctorate from The Johns Hopkins University School of Medicine.

Michael A. Egan active positions

Companies	Position	Start
Profectus BioSciences, Inc. Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD.	Corporate Officer/Principal	2007-12-31

All active positions of Michael A. Egan

Former positions of Michael A. Egan

Companies	Position	End
Wyeth Research Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA.	Corporate Officer/Principal	-

See the detail of Michael A. Egan's experience

Training of Michael A. Egan

The Johns Hopkins University School of Medicine	Doctorate Degree
Northern Arizona University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael A. Egan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Profectus BioSciences, Inc. Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD.	Health Technology
Wyeth Research Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA.	Commercial Services